Gene · 1650
Papers1,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| scMNMF: a novel method for single-cell multi-omics clustering based on matrix factorization. | Brief Bioinform | 2024 | 38754408 | PubTator, text mining | PubMed |
| Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB. | Cell | 2024 | 38670073 | Swiss-Prot, curated | PubMed |
| ALKBH1 promotes HIF-1α-mediated glycolysis by inhibiting N-glycosylation of LAMP2A. | Cell Mol Life Sci | 2024 | 38472355 | PubTator, text mining | PubMed |
| DDOST is associated with tumor immunosuppressive microenvironment in cervical cancer. | Discov Oncol | 2024 | 38460058 | PubTator, text mining | PubMed |
| Cell surface expression of Ribophorin I, an endoplasmic reticulum protein, over different cell types. | Int J Biol Macromol | 2024 | 38373565 | PubTator, text mining | PubMed |
| Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver. | Nature | 2024 | 38297127 | PubTator, text mining | PubMed |
| N-glycosylation as a eukaryotic protective mechanism against protein aggregation. | Sci Adv | 2024 | 38295165 | PubTator, text mining | PubMed |
| Genome-wide CRISPR/Cas9 screen identifies regulators of BCMA expression on multiple myeloma cells. | Blood Cancer J | 2024 | 38272874 | PubTator, text mining | PubMed |
| Inherited Retinal Degeneration Caused by Dehydrodolichyl Diphosphate Synthase Mutation-Effect of an ALG6 Modifier Variant. | Int J Mol Sci | 2024 | 38256083 | PubTator, text mining | PubMed |
| MIIP downregulation drives colorectal cancer progression through inducing peri-cancerous adipose tissue browning. | Cell Biosci | 2024 | 38245780 | PubTator, text mining | PubMed |
| Targeting DAD1 gene with CRISPR-Cas9 system transmucosally delivered by fluorinated polylysine nanoparticles for bladder cancer intravesical gene therapy. | Theranostics | 2024 | 38164146 | PubTator, text mining | PubMed |
Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV randomized controlled trial. | Diabetes Metab | 2024 | 38097011 | PubTator, text mining | PubMed |
| Adult-onset neurodegeneration in XMEN disease. | J Neuroimmunol | 2024 | 38041964 | PubTator, text mining | PubMed |
| Molecular Insight into Gastric Cancer Invasion-Current Status and Future Directions. | Cancers (Basel) | 2023 | 38201481 | PubTator, text mining | PubMed |
| Canonical IRE1 function needed to sustain vigorous natural killer cell proliferation during viral infection. | iScience | 2023 | 38162021 | PubTator, text mining | PubMed |
AGER-1 Long Non-Coding RNA Levels Correlate with the Expression of the Advanced Glycosylation End-Product Receptor, a Regulator of the Inflammatory Response in Visceral Adipose Tissue of Women with Obesity and Type 2 Diabetes Mellitus. | Int J Mol Sci | 2023 | 38139276 | PubTator, text mining | PubMed |
| Codon optimization regulates IgG3 and IgM expression and glycosylation in N. benthamiana. | Front Bioeng Biotechnol | 2023 | 38125307 | PubTator, text mining | PubMed |
| Remodeling of the ribosomal quality control and integrated stress response by viral ubiquitin deconjugases. | Nat Commun | 2023 | 38097648 | PubTator, text mining | PubMed |
| Deficiency of N-linked glycosylation impairs immune function of B7-H6. | Front Immunol | 2023 | 38035117 | PubTator, text mining | PubMed |
| Discovery and Visualization of the Hidden Relationships among N-Glycosylation, Disulfide Bonds, and Membrane Topology. | Int J Mol Sci | 2023 | 38003370 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1650/papers?page=4